DCAF4L2 and metabolic dysfunction-associated steatohepatitis: DNA hypomethylation occurring at the precancerous NASH stage (N samples) was clearly inherited by HCCs (T samples) (Fig. 2), suggesting that precancerous hepatocytes showing DCAF4L2 overexpression might gain a growth advantage and show clonal expansion.